Gene therapy for haemophilia B

20Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

AAV virus mediated transfer of factor IX to humans is safe and effective at three dose levels. Two subjects treated at highest dose level developed immune mediated transaminitis which resolved on a short course of Prednisolone. Beneficial effects in terms of continuous elevation of factor IX level above base line was seen in all subjects, continuing for over 18 months. Further study of this treatment method is warranted. © 2012 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Tuddenham, E. (2012). Gene therapy for haemophilia B. Haemophilia, 18(SUPPL.4), 13–17. https://doi.org/10.1111/j.1365-2516.2012.02823.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free